Treatment strategy for hepatocellular carcinoma (HCC) requires optimal selection of therapies based on various factors related to tumor condition and liver functional reserve. Although several evidence-based guidelines have been proposed for the treatment of HCC, the criteria and range of indications differ among these guideli-
Resection is the mainstay of treatment for resectable HCC. 5, 6 In addition to the surgical treatments, there are various therapeutic options, including locoregional treatment, transcatheter arterial chemoembolization (TACE), and systemic treatment. Moreover, the background of HCC treatment differs widely according to the condition of each institution and availability of donors for transplantation.
We review the current topics of HCC treatment regarding the position of surgical treatments from the standpoints of comparison of guidelines, early-stage HCC and advanced-stage HCC. We also discus laparoscopic liver resection, a surgical technique that has become popular recently.
| CURREN T STATUS OF TH E TREATMENT GUID ELINES FOR HEPATOCELLULAR CARCINOMA 2.1 | TNM staging
The TNM staging system is based on three key pieces of information. T describes the number and size of the primary tumor(s), and whether the tumor has grown into nearby blood vessels. N describes the extent of spread to regional lymph nodes. M indicates whether the tumor has metastasized to distant parts of the body. The most recent version of the TMN staging system (8th edition) was published in 2017, coming into effect on 1 January 2018. 7 Some significant changes in the T classification have been made, relative to the 7th edition. T1 was subdivided into two subcategories: T1a (solitary tumor ≤2 cm) and T1b (solitary tumor >2 cm, without vascular invasion). There was no change to the T2 category (solitary tumor with vascular invasion or multiple tumors, none >5 cm). The previous T3a
category was re-categorized as T3 (multiple tumors, at least one of which is >5 cm), whereas tumors that were previously categorized as T3b are now included in T4 (tumors involving a major branch of the portal vein or hepatic vein, or tumors with direct invasion of adjacent organs or perforation of the visceral peritoneum).
Because the TNM staging system lacks factors related to liver functional reserve, it may not be adequate for patients with severe underlying liver disease. 9 
| BCLC staging classification
The BCLC group was created in 1986 by Jordi Bruix and Concepcio
Bru. Since the staging system was first published in 1999, it has been updated according to evidence-based data. 8 The BCLC staging system comprises five stages that are based on the extent of the primary lesion, performance status, liver func- (Table 1) . 13 In general, indication for hepatic resection is decided based on liver function and extent of tumor development. Appropriate candidates for surgical treatment vary according to the guidelines.
| Liver function
Liver function is assessed on the basis of the Child-Pugh classifica- The EASL-EORTC guidelines added a recommendation of anatomical resection that has ensured a surgical approach, based on sound oncological principles, although associated with a modest decrease in early recurrence. 22, 23 The guidelines also refer to the choice of preoperative portal vein embolization (PVE) in order to increase the residual liver volume if a major resection is planned. 5 The AASLD guidelines were based on the BCLC staging system in the previous version (2011). 14 resectability. The APASL guideline recommends that, when judging resectability, both technical and oncological aspects should be taken into consideration. 24 In the NCCN guidelines, cases of a single nodule without vascular invasion are considered the best candidates for surgery, whereas cases matching the United Network for Organ Sharing (UNOS) criteria (single lesion ≤5 cm, or 2 or 3 lesions ≤ 3 cm) are candidates for both liver transplantation and surgical resection. 25 The Korean guidelines have adopted the fifth version of the modified International Union for Cancer Control (UICC) staging system. Based on this system, the Korean guidelines state that resection can be considered in patients with ≤3 nodules without vascular invasion. 19 The Japanese guidelines also recommend that resection can be considered in patients with ≤3 nodules, regardless of tumor size.
In addition, portal vein tumor thrombus should not be precluded from surgical resection, so that these guidelines recommend the widest surgical indication. 18 However, the newly updated Japan Society of Hepatology (JSH) guidelines recommend that the optimal treatment strategy for HCC with vascular invasion should be selected from TACE, liver resection, hepatic arterial infusion therapy, and molecular targeted drugs, according to the conditions of individual cases. 26 The Chinese guidelines define general surgical indication for cases with three or fewer tumors, meanwhile proposing palliative liver resection and seeking potential surgical therapy for advanced cases, including resection of portal vein tumor thrombus (PVTT) and concomitant splenectomy for cases with portal hypertension. 27 
| Liver transplantation
Liver transplantation is an appropriate strategy for patients with localized HCC who are not candidates for resection. The Milan criteria, which were established by Mazzaferro in 1996, have been applied widely around the world in the selection of patients for liver transplantation. 28 The Milan criteria are too strict in terms of posttransplant recurrence rates and could be expanded, as long as patient outcome is not impaired. The University of California, San Because the BCLC recommends a narrower surgical indication, strictly conforming to these guidelines could fail to decide the optimal treatment for patients. In fact, 50% of patients with intermediate-to advanced-stage disease defined by the BCLC routinely underwent surgical resection. 34 In contrast, only 10% 40 Chong et al 41 showed the superiority of resection over RFA in terms of OS and DFS in patients with BCLC stage 0/A HCC.
Four randomized controlled trials (RCT) have been reported so far. [42] [43] [44] [45] Huang et al 43 compared the outcome between resection and RFA in patients with HCC which met the Milan criteria, and showed the superiority of resection (Table 2) . However, the conclusion stating the superiority of resection to RFA cannot be accepted completely because some studies included patients with HCC of 2 cm or greater in size, for which ablation seems ineffective, and because RFA was more likely to be selected for patients with impaired liver functional reserve, so that there may be a difference in patient background, suggesting the possibility of selection bias. 39, 48 Indeed, in daily clinical practice, treatment regimens are determined not only by the size and number of tumors but also by the location of tumors and their relationship to blood vessels, as well as the liver functional reserve of patients with Child A classification. Some reports also discussed the cost-benefit of treatments, in addition to tumor factors and liver functional reserve, and suggested that the optimal treatment should be considered not only based on tumor factors defined in the guidelines but also on more detailed conditions. recommend clinical study of sorafenib or systemic chemotherapy for HCC with tumor thrombus extending to the major branch of the portal vein. 51 However, the outcome of sorafenib treatment for advanced HCC does not seem favorable. 52 We will discuss surgical treatment for advanced HCC, compared with transarterial chemoembolization, adjuvant therapy, and systemic chemotherapy. It has been shown that preoperative radiotherapy for HCC associated with PVTT reduced the size of PVTT and showed better progression-free and survival rates than surgery alone, 61 suggesting efficacy of preoperative radiotherapy for PVTT. 
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From an oncological point of view, laparoscopic liver resection has been shown to be non-inferior to laparotomy in many retrospective studies, including those which used PSM to minimize differences in the backgrounds of patients. As shown in Table 3 , according to previous meta-analysis or PSM-based studies comparing LLR and OLR, LLR is associated with smaller amounts of blood loss, almost similar operative time (although the operative time was reported to be longer in LLR than in OLR in some reports), fewer complications, and shorter hospital stay. Regarding the long-term treatment outcome for HCC, there were no significant differences in overall survival and DFS between LLR and OLR. [75] [76] [77] [78] [79] [80] [81] At present, there is no RCT comparing LLR and OLR, but there seems to be no difference in the long-term outcome between LLR and OLR for HCC. In addition, it is pointed out that LLR may be superior to OLR in patients with impaired liver function. 82, 83 Most patients with HCC have underlying chronic liver disease, and their liver function is often impaired. Therefore, indication for surgery should be considered regarding both the oncological therapeutic effects and the risk of postoperative complications, especially the development of liver failure. Survival outcomes were comparable between LLR and OLR in patients with early-stage HCC; however, the laparoscopic approach provides a better diseasefree survival rate in patients with advanced stage HCC. 84 The differences are considered to be caused by low surgical stress, including less blood loss and less tissue manipulation, and so on. The feature of laparoscopic approach will lead to expanding the surgical indications for HCC with a background of chronic liver disease.
Safety is the primary concern regarding the introduction of laparoscopic liver resection; therefore, guidelines are needed for that purpose. In addition to conventional classification (minor and major liver resection), a scoring system of surgical difficulty on the basis of liver functional reserve and tumor factors, including tumor location and relationship to major vessels, has been proposed in an attempt to serve as a guideline for training, [85] [86] [87] and has been validated to correlate with surgical outcome in the clinical setting. [88] [89] [90] A step-by-step training system appropriate for the difficulty score and individual surgical skill can lead to safe expansion of the indication of LLR.
| CONCLUSION S
We have reviewed the current topics of HCC treatment, focusing on surgical therapy. Introduction of a new modality for ablation and a 
